Evaluation the antibacterial effects of Echinophora platyloba extracts against some Salmonella species

Authors

  • Saeed Babaie Molecular Biology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran

Keywords:

antimicrobial action, echinophora platyloba, salmonella

Abstract

Introduction: Salmonellosis, which is caused by nontyphoid salmonella bacteria, is one of the most common foodborne diseases, and it causes gastrointestinal infections worldwide, most of which are limited gastroenteritis that requires antimicrobial treatment. The aim of this study was to investigate the effects of echinophora platyloba extract on inhibiting the growth of Salmonella typhi, Salmonella enteritidis, and salmonella choleraesuis. 

Methods: Echinophora Platyloba extract was collected in the East Azarbaijan Province in Iran in June 2015. Weeds, infected plants, and dried roots were separated and removed. After drying and grinding the plant, 100 grams of powder were weighed, and the extraction of the plant was carried out by percolation. This study tested the Minimum Inhibitory Concentration (MIC) by the broth micro dilution method and Minimum Bactericidal Concentration (MBC). All of the data were analyzed by SPSS statistical software, version 22.0. One-Way ANOVA and the Duncan test were used to compare the effect of various concentrations of the extract on each type of bacteria.

Results:  Our results indicated that, in 250 mg/ml of extracts discs, the largest growth inhibition zones were formed, and they were 26.11 ± 1.16, 21.23 ± 0.89, and 19.65 ± 0.60 in S. enteritidis, S. typhi, and S. choleraesuis groups, respectively. The statistical results indicated that, in each type of bacteria, there was a statistical difference (p < 0.01) between the various concentrations of the extracts and the chloramphenicol discs. Also, it was indicated that this extract at a concentration of 150 mg/ml had a germicidal effect on S. enteritidis and S. typhi bacteria and that 250 mg/ml had a bactericidal effect on S. choleraesuis. 

Conclusion: The results of this study indicated that E. platyloba extract has potential effects as antimicrobial agents.

References

Cowan MM. Plant products as antimicrobial agents. Clin Microbiol Rev. 1999; 12(4): 564-82. doi:

1016/0378-8741(95)01347-4, PMID: 10515903, PMCID: PMC88925.

Borris RP. Natural products research: perspectives from a major pharmaceutical company. J

Ethnopharmacol. 1996; 51(1): 29-38. doi: 10.1016/0378-8741(95)01347-4, PMID: 9213624.

Schultes R. The Kingdom of plants, 208. Medicines from the earth Mc Grow–Hill Book Co, New York,

NY. 1978: 208-9.

Clark AM. Natural products as a resource for new drugs. Pharm Res. 1996; 13(8): 1133-41. PMID:

Corns CM. Herbal remedies and clinical biochemistry. Ann Clin Biochem. 2003; 40(5): 489-507. doi:

1258/000456303322326407, PMID: 14503986.

Nourozi M. Evaluation of photochemical and antimicrobial effect of Echinophora platyloba: PhD Thesis.

Faculty of Pharmacy of Tehran University of Medical Sciences. Pharmacogenosy Department. 1989, 35- 40; 1989.

Sadrai H, Asghari G, Yaghobi K. Evaluation of ethanolic extract and essential oil of Echinophora platyloba

on isolated ileum of rat. Res Med. 2002; 7: 150-5.

Vanden D, vancechoottee M. Susceptibility testing of fluconazole by NCCLS Broth Macrodilotion Method,

E-Test, and disk Diffusion for application in therovtine laboratory. J Clin Microbiol. 2002; 40(3): 918-21.

doi: 10.1128/JCM.40.3.918-921.2002, PMCID: PMC120224

Glamočlija JM, Soković MD, Šiljegović JD, Ristić MS, Ćirić AD, Grubišić DV. Chemical composition and

antimicrobial activity of Echinophora spinosa L.(Apiaceae) essential oil. Rec Nat Prod. 2011; 5: 319-23.

Hashemi P, Abolghasemi MM, Ghiasvand AR, Ahmadi S, Hassanvand H, Yarahmadi A. A comparative

study of hydrodistillation and hydrodistillation–solvent microextraction methods for identification of

volatile components of Echinophora cinerea. Chromatographia. 2009; 69(1-2): 179-82. PMCID:

PMC4313014.

Herikstad H, Motarjemi Y, Tauxe R. Salmonella surveillance: a global survey of public health serotyping.

Epidemiol Infect. 2002; 129(01): 1-8. doi: 10.1017/S0950268802006842. PMID: 12211575, PMCID:

PMC2869853.

Eshraghi S, Dalall S, Mehdi M, Fardsanei F, Zahraii Salehi T, Ranjbar R, et al. Salmonella enteritidis and

antibiotic resistance patterns: a study on 1950 children with diarrhea. Tehran Univ Med J. 2010; 67(12):

-82.

Burow H. [Increase in infections caused by Salmonella enteritidis--causes and possibilities for

intervention]. Gesundheitswesen. 1993; 55(6): 285-93. PMID: 8358185.

Ramadan F, Unni A, Hablas R, Rizk M. Salmonella-induced enteritis. Clinical, serotypes and treatment. J

Egypt Public Health Assoc. 1991; 67(3-4): 357-67. PMID: 1296967.

Ranjbar R, Giammanco GM, Aleo A, Plano MRA, Naghoni A, Owlia P, et al. Characterization of the First

Extended-Spectrum β-Lactamase–Producing Nontyphoidal Salmonella Strains Isolated in Tehran, Iran.

Foodborne Pathog Dis. 2010; 7(1): 91-5. doi: 10.1089/fpd.2009.0382, PMID: 19785534.

Amini K, Salehi TZ, Nikbakht G, Ranjbar R, Amini J, Ashrafganjooei SB. Molecular detection of invA and

spv virulence genes in Salmonella enteritidis isolated from human and animals in Iran. Afr J Microbiol Res.

; (4): 2202-10.

Ranjbar R, Salimkhani E, Sadeghifard N, Yazdi J, Morovvati S, Jonaidi N, et al. An outbreak of

gastroenteritis of unknown origin in Tehran, July 2003. Pak J Biol Sci. 2007; 10(7): 1138-40. doi:

3923/pjbs.2007.1138.1140, PMID: 19070067.

Ranjbar R, Mirzaee A. Determining o f the variety of genotypes in Salmonella typhimurium by ERIC-PCR.

J Babol Univ Med Sci. 2012; 15: 51-7.

Ranjbar R, Sarshar M. Genetic diversity of clinical strains of Salmonella enterica serovar Typhimurium.

Journal Mil Med. 2012; 14(2): 143-7.

Ranjbar R, Giammanco GM, Farshad S, Owlia P, Aleo A, Mammina C. Serotypes, antibiotic resistance,

and class 1 integrons in Salmonella isolates from pediatric cases of enteritis in Tehran, Iran. Foodborne

Pathog Dis. 2011; 8(4): 547-53. doi: 10.1089/fpd.2010.0736, PMID: 21204690.

Naghoni A, Ranjbar R, Tabaraie B, Farshad S, Owlia P, Safiri Z, et al. High prevalence of integron- mediated resistance in clinical isolates of Salmonella enterica. Jpn J Infect Dis. 2010; 63(6): 417-21. PMID:

Shirazi M, Ranjbar R, Eshraghi S, Amin G, Nouri MS, Bazzaz N. Inhibitory effects of Sage extract on the

growth of enteric bacteria. Pak J Biol Sci. 2008; 11(3): 487-9. PMID: 18817180.

Chandra PK, Pitamber PD, Bikram SS. Developing the medicinal plant sector in northern India: challenges

and opportunities. J Ethnobiol Ethnomed. 2006; 2(32): 1-15. doi: 10.1186%2F1746-4269-2-32. PMCID:

PMC1562365.

Meng N, Lan-ying L, Yun-dong Y. Anti-fungal test of composite agastache lotion on seven pathogenic

fungi and its clinical application. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2003; 23(6): 414-6. doi:

1007/BF02838046. PMID: 12872390.

Quiroga E, Sampietro A, Vattuone M. In vitro fungitoxic activity of Larrea divaricata cav. extracts. Lett

Appl Microbiol. 2004; 39(1): 7-12. doi: 10.1111/j.1472-765X.2004.01521.x, PMID: 15189281.

Shin S, Kang CA. Antifungal activity of the essential oil of Agastache rugosa Kuntze and its synergism

with ketoconazole. Lett Appl Microbiol. 2003; 36(2): 111-5. doi: 10.1046/j.1472-765X.2003.01271.x,

PMID: 12535132.

Nwosu MO, Okafor JI. Preliminary studies of the antifungal activities of some medicinal plants against

Basidiobolus and some other pathogenic fungi. Mycoses. 1995; 38(5‐6): 191-5. doi: 10.1111/j.1439- 0507.1995.tb00048.x, PMID: 8531930.

Phongpaichit S, Subhadhirasakul S, Wattanapiromsakul C. Antifungal activities of extracts from Thai

medicinal plants against opportunistic fungal pathogens associated with AIDS patients. Mycoses. 2005;

(5): 333-8. doi: 10.1111/j.1439-0507.2005.01142.x, PMID: 16115104.

Zaidi MA, Crow SA. Biologically active traditional medicinal herbs from Balochistan, Pakistan. J

Ethnopharmacol. 2005; 96(1): 331-4. doi: 10.1016/j.jep.2004.07.023, PMID: 15588685.

Renault S, De Lucca A, Boue S, Bland J, Vigo C, Selitrennikoff C. CAY-I, a novel antifungal compound

from cayenne pepper. Med Mycol. 2003; 41(1): 75-82. doi: 10.1080/mmy.41.1.75.82, PMID: 12627807.

Mel'nichenko E, Kirsanova M, Grishkovets V, Tyshkevich L, Krivorutchenko I [Antimicrobial activity of

saponins from Hedera taurica C a r r]. Mikrobiol Z. 2002; 65(5): 8-12, PMID: 14723156.

Kariba R, Houghton P, Yenesew A. Antimicrobial activities of a new schizozygane indoline alkaloid from

Schizozygia coffaeoides and the revised structure of isoschizogaline. J Nat Prod. 2002; 65(4): 566-9.

PMID: 11975502.

Pirbalouti AG, Malekpoor F, Enteshari S, Yousefi M, Momtaz H, Hamedi B. Antibacterial activity of some

folklore medicinal plants used by Bakhtiari tribal in Southwest Iran. Int J Biol. 2010; 2(2): p55. doi:

5539/ijb.v2n2p55.

Cos P, Vlietinck AJ, Berghe DV, Maes L. Anti-infective potential of natural products: how to develop a

stronger in vitro ‘proof-of-concept’. J Ethnopharmacol. 2006; 106(3): 290-302. doi:

1016/j.jep.2006.04.003, PMID: 16698208.

Hashemi M, Ehsani A, Jazani NH, Aliakbarlu J, Mahmoudi R. Chemical composition and in vitro

antibacterial activity of essential oil and methanol extract of Echinophora platyloba DC against some of

food-borne pathogenic bacteria. Vet Res Forum. 2013; 4(2): 123. PMCID: PMC4313014.

Entezari M, Hashemi M, Ashki M, Ebrahimian S, Bayat M, Azizi Saraji A, et al. Studying the effect

Echinophora platyloba extract on bactira (Staphilococus aureus and Pseudomonas aeroginosa) and fungi

(Candidia albicans, Aspergilus flavus and Aspergilus niger) in vitro. World J Med Sci. 2009; 4(2): 89-92.

Majid A, Mohaddesse M, Mahdi D, Mahdi S, Sanaz S, Kassaiyan N. Overview on Echinophora platyloba,

a synergistic anti-fungal agent candidate. J Yeast Fungal Res. 2010; 1(5): 88-94.

Published

2022-02-21